20 results
Thumbnail

- D1.536 - Immunological basis of coexisting slowly progressive insulin-dependent diabetes mellitus (SPIDDM) and Vogt–Koyanagi–Harada disease (VKH)

Thumbnail

- D1.537 - Immunopharmacogenomics as a Systems Medicine Framework for Precision Therapy in Allergic and Immune Mediated Diseases

Thumbnail

- D1.538 - First Report of the SERPING1 c.52-1G>A Variant in a Chinese HAE Pedigree: Severe Abdominal Phenotype Correlated with Attack-Phase Imaging

Thumbnail

- D1.540 - Automated generation of real-world clinical databases in Allergy: a data-driven research framework

Thumbnail

- D1.541 - Addressing Allergy undergraduate education: Strategic Reforms for Specialist-Led Allergy teaching in Medical Curricula. A EAACI Tailored Education Committee Task Force

Thumbnail

D3.243 - Food allergy in children with inherited epidermolysis bullosa: possible role of transcutaneous sensitization and features of the clinical course

Thumbnail

D3.240 - Differential microRNA expression in chronic spontaneous urticaria in relation to treatment response

Thumbnail

D3.241 - How Clinical Control of Chronic Urticaria influence in mental health

Thumbnail

D3.242 - SDRIFE induced by multiple systemic corticosteroids

Thumbnail

D3.244 - STK4 Deficiency Presenting with Epidermodysplasia Verruciformis

Thumbnail

D3.246 - A Novel Mutation in a Case of Deficiency of Interleukin-1 Receptor Antagonist in a Filipino Male Child

Thumbnail

D3.247 - Skin Involvement Is One Of The Common Signs In Children With Inborn Errors Of Immunity

Thumbnail

D3.251 - Prevention of Irritant Contact Dermatitis Among Dental Students

Thumbnail

D3.252 - Water-induced localized urticaria: A rare case of aquagenic urticaria

Thumbnail

D3.253 - Two Infant Cases Diagnosed with Bullous Mastocytosis, a Rare Variant of Diffuse Cutaneous Mastocytosis

Thumbnail

D3.445 - Validation of a Novel Serum-Based Indirect Basophil Activation Test (iBAT) to Evaluate Efficacy of a Pivotal Phase III PQ Grass Immunotherapy Trial

Thumbnail

D3.437 - Impact of benralizumab on fatigue and health-related quality of life in patients with hypereosinophilic syndrome: findings from the NATRON phase 3 trial

Thumbnail

D3.438 - Clinical outcomes with navenibart according to baseline attack rate, body mass index, and age: results of the ALPHA-STAR trial

Thumbnail

D3.447 - Pre-clinical Toxicology and Immunogenicity Evidence as a Precursor of the Successful Phase I/IIA Study with VLP Peanut

Thumbnail

D3.448 - Use of Sebetralstat as Short-term Prophylaxis for Patients with Hereditary Angioedema: Results from the KONFIDENT-S Study